Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 12011120

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2002 May 15
First author
Silverman LR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2002 May 15;20(10):2415-6. doi: 10.1200/JCO.2002.20.10.2415.
    note
    Source null
    related pmid
    12011118
    relationship
    Comment in

Authors and identifiers

  1. name
    Silverman LR
    type
    Author
  2. name
    Demakos EP
    type
    Author
  3. name
    Peterson BL
    type
    Author
  4. name
    Kornblith AB
    type
    Author
  5. name
    Holland JC
    type
    Author
  6. name
    Odchimar-Reissig R
    type
    Author
  7. name
    Stone RM
    type
    Author
  8. name
    Nelson D
    type
    Author
  9. name
    Powell BL
    type
    Author
  10. name
    DeCastro CM
    type
    Author
  11. name
    Ellerton J
    type
    Author
  12. name
    Larson RA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Silverman LR
    type
    Author
  2. name
    Demakos EP
    type
    Author
  3. name
    Peterson BL
    type
    Author
  4. name
    Kornblith AB
    type
    Author
  5. name
    Holland JC
    type
    Author
  6. name
    Odchimar-Reissig R
    type
    Author
  7. name
    Stone RM
    type
    Author
  8. name
    Nelson D
    type
    Author
  9. name
    Powell BL
    type
    Author
  10. name
    DeCastro CM
    type
    Author
  11. name
    Ellerton J
    type
    Author
  12. name
    Larson RA
    type
    Author
bibliography ids
  1. nci-bib-2ceafc5b271b7b639cebe5a3
book metadata
content sha256
80b399bae1e6c6c5d005ece582b052c9efe5f57137d90139492b33ec1c189fe4
document type
citation
dois
  1. 10.1200/JCO.2002.04.117
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:12011120
immutable id
pubmed:12011120@80b399bae1e6c6c5d005ece582b052c9efe5f57137d90139492b33ec1c189fe4
journal
abbreviation
J Clin Oncol
issn electronic
Source null
issn print
0732-183X
issue
10
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2429-40
volume
20
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2002 May 15;20(10):2415-6. doi: 10.1200/JCO.2002.20.10.2415.
    note
    Source null
    related pmid
    12011118
    relationship
    Comment in
outcomes validated
false
pmid
12011120
provenance
batch id
ced7794d3512d3f45188
provider
NCBI PubMed ESummary
record sha256
08603fb5be4cf3b4d7c549c60b351542fa90dd60f28e43a4aa3d79443c51d0eb
response sha256
782bfef1f051086807ee9551561575ae64b9ca1f941a87d5259ff83e5424435e
retrieved at
2026-09-09T23:45:46.208577+00:00
publication date
display
2002 May 15
precision
day
year
2002
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase III
  3. Comparative Study
  4. Journal Article
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
  7. Research Support, U.S. Gov't, P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/12011120/
title
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

Preserved source evidence · Not medical advice